Back
Tilray Brands Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
29
TLRY
Tilray Brands
Last Price:
1.94
Seasonality Move:
5.28%
Sell
50
AUPH
Aurinia Pharmaceuticals
Last Price:
5.15
Seasonality Move:
3.33%
Sell
29
Tilray Brands (TLRY)
is a Sell
Is Tilray Brands a Buy, Sell or Hold?
- The current Tilray Brands [TLRY] share price is $1.98. The Score for TLRY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- TLRY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.12. The Score for AUPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TLRY Stock Price Chart
What is Tilray Brands's stock price today?
-
The Tilray Brands share price today is $1.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TLRY is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.12
The current trend is relatively stagnant and AUPH is experiencing slight selling pressure.
TLRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 49.7 | Sell |
| Chaikin Money Flow: | -22794556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.7 - 2.36) | Sell |
| Bollinger Bands (100): | (1.73 - 2.25) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 49.58 | Sell |
| Chaikin Money Flow: | -28648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.94 - 5.14) | Buy |
| Bollinger Bands (100): | (5 - 8.22) | Sell |
TLRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.02 | Sell |
| 20-day SMA: | 1.89 | Buy |
| 50-day SMA: | 1.97 | Buy |
| 200-day SMA: | 2.1 | Sell |
| 8-day EMA: | 2.01 | Sell |
| 20-day EMA: | 1.99 | Sell |
| 50-day EMA: | 1.99 | Sell |
| 200-day EMA: | 2.13 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.09 | Buy |
| 20-day SMA: | 5.04 | Buy |
| 50-day SMA: | 5.18 | Sell |
| 200-day SMA: | 7.67 | Sell |
| 8-day EMA: | 5.1 | Buy |
| 20-day EMA: | 5.09 | Buy |
| 50-day EMA: | 5.45 | Sell |
| 200-day EMA: | 7.22 | Sell |
Tilray Brands Earnings Growth & TLRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $0.06 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Tilray Brands Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||